Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Asthenia, Bedridden, Chills, Cough
Clinical narrative: cough; blurry vision in his right eye; can't eat and lost his appetite; he could not move; stomach ache where he felt he would throw up; lost all of his strength; in bed; whole body ache; shivers; headache; 1st dose - J and J / booster - Moderna; shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028K21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: J and J (Batch number 1802070) in 2021. Past adverse reactions to the above products included Sickness with J and J.    On 14-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2022, the patient experienced DYSPNOEA (shortness of breath) (seriousness criterion medically significant), DECREASED APPETITE (can't eat and lost his appetite), MOVEMENT DISORDER (he could not move), ABDOMINAL PAIN UPPER (stomach ache where he felt he would throw up), ASTHENIA (lost all of his strength), BEDRIDDEN (in bed), MYALGIA (whole body ache), CHILLS (shivers), HEADACHE (headache) and INTERCHANGE OF VACCINE PRODUCTS (1st dose - J and J / booster - Moderna). 14-Jan-2022, the patient experienced VISION BLURRED (blurry vision in his right eye). 14-Jan-2022, the patient experienced DYSPNOEA (shortness of breath) (seriousness criterion medically significant), DECREASED APPETITE (can't eat and lost his appetite), MOVEMENT DISORDER (he could not move), ABDOMINAL PAIN UPPER (stomach ache where he felt he would throw up), ASTHENIA (lost all of his strength), BEDRIDDEN (in bed), MYALGIA (whole body ache), CHILLS (shivers), HEADACHE (headache) and INTERCHANGE OF VACCINE PRODUCTS (1st dose - J and J / booster - Moderna). On an unknown date, the patient experienced COUGH (cough). On 16-Jan-2022, MOVEMENT DISORDER (he could not move) was resolving, BEDRIDDEN (in bed) had resolved. At the time of the report, DYSPNOEA (shortness of breath), VISION BLURRED (blurry vision in his right eye), DECREASED APPETITE (can't eat and lost his appetite), ABDOMINAL PAIN UPPER (stomach ache where he felt he would throw up), ASTHENIA (lost all of his strength), MYALGIA (whole body ache), CHILLS (shivers) and HEADACHE (headache) was resolving, COUGH (cough) had not resolved and INTERCHANGE OF VACCINE PRODUCTS (1st dose - J and J / booster - Moderna) outcome was unknown.            No concomitant medications were provided. The patient reported that 15 minutes after the injection he had blurry vision in his right eye which he thinks is his dominant eye. He stated that he had a headache, stomach ache where he felt he would throw up, he had shivers, couldn't eat and lost his appetite, he could not move and lost all of his strength, he had a whole body ache and shortness of breath. Patient was in bed from 14-Jan-2022 to 16-Jan-2022. He stated that he was getting better. He was having cough at the time of report. Patient stated that he was pressured to get the vaccine. No treatment information were given.  Company comment: This is a spontaneous case concerning a 64-year-old male patient with no medical history reported, who experienced the unexpected serious event of Dyspnoea (reported as medically significant by reporter), as well as non-serious events of Cough, Vision blurred, Decreased appetite, Movement disorder, Abdominal pain upper, Asthenia, Bedridden, Myalgia, Chills and Headache. The events started developing on the same date after the third dose of mRNA-1273 vaccine. The previous dose of vaccine was of another manufacturer, which suggests Interchange of vaccine products. Rechallenge was not applicable as this was the third dose. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-454224 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a 64-year-old male patient with no medical history reported, who experienced the unexpected serious event of Dyspnoea (reported as medically significant by reporter), as well as non-serious events of Cough, Vision blurred, Decreased appetite, Movement disorder, Abdominal pain upper, Asthenia, Bedridden, Myalgia, Chills and Headache. The events started developing on the same date after the third dose of mRNA-1273 vaccine. The previous dose of vaccine was of another manufacturer, which suggests Interchange of vaccine products. Rechallenge was not applicable as this was the third dose. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.